Axial3D provides personalized surgical solutions by transforming medical images into actionable 3D data, helping medical device companies and hospitals.

Axial3D

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Elihu Thomson

Thomas Edison

GE HealthCare Technologies Inc.

Meltio offers wire-laser metal 3D printing technology, specifically a cost-effective wire laser metal deposition technology that stacks layers of weld beads using a laser-generated melt pool.

Meltio

Quixel offers a vast library of 3D assets and tools for artists and developers in the gaming and film industries, self-described as a provider of Megascans.

Metric
Company Name	Axial3D	GE HealthCare Technologies Inc.	Meltio	Quixel
Symbol		GEHC
MSH ID	COM:AXIAL3D	COM:GEHEALTHCARE	COM:MELTIO3D	COM:QUIXEL
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Technology	Technology
Industry	Medical Technology	Medical - Healthcare Information Services	Industrial Manufacturing	Software & Digital Media
Country	GB	US	ES	US
Stage
Employee Count		51K
Website	axial3d.com	gehealthcare.com	meltio3d.com	quixel.com
LinkedIn		gehealthcare
Founders

Metric
Market Cap		36.12B
Enterprise Value
Monthly Web Traffic		1.37M
Web Traffic Growth		0.23
Valuation
Raised Capital		1.17B

Metric
Revenue		19.55B
Revenue (LTM)
Revenue (NTM)
Gross Profit		7.92B
EBITDA		2.44B
Operating Income		2.44B
Net Income		3.10B
EPS		6.82
Diluted EPS		6.78
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.41
Operating Profit Margin		0.13
EBITDA Margin		0.12
Net Profit Margin		0.08
Return on Equity		0.22
Return on Assets		0.05
Return on Capital Employed		0.11

AXIA

COM:AXIAL3D

Axial3D

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		19.27
P/B Ratio		4.68
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		2.15
EV Multiple		10.08

Metric
Days Sales Outstanding		84.00
Days Payables Outstanding		87.39
Days Inventory Outstanding		64.08
Operating Cycle		141.20
Cash Conversion Cycle		51.81
Asset Turnover		0.61

Metric
Operating Cash Flow		2.10B
Free Cash Flow		1.71B
Cash Flow to Debt		0.23
Operating Cash Flow/Sales		0.11
Free Cash Flow Yield		0.05

Metric
Cash & Equivalents		2.50B
Accounts Receivable		-185M
Inventory		1.96B
Goodwill		12.94B
Debt to Capitalization		0.58
Debt to Assets		0.32
Current Ratio		1.25
Quick Ratio		0.83

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		-0.02
R&D to Revenue		0.06
SG&A to Revenue